A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.
The purpose of this study is to explore the role of adjuvant chemo-radiotherapy in patients with local advanced gastric cancer.
Gastric Cancer
RADIATION: Adjuvant Concurrent Chemo-radiotherapy|DRUG: Adjuvant chemotherapy for active comparator group|DRUG: Adjuvant chemotherapy for experimental group
Disease-free survival, 3 years
Local recurrence free survival, 3 years|Distant metastasis free survival, 3 years|Over all survival, 3 years|Adverse Event, 3 years
The purpose of this study is to explore the role of adjuvant chemo-radiotherapy in patients with local advanced gastric cancer.